IPO
Mersana Therapeutics, Inc.
They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Symbol
MRSN
Price Range
$14.00 - $16.00
Anticipated Date
TBD
Underwriters
J.P. Morgan, Cowen and Company, Leerink Partners, Wedbush PacGrow
To view the prospectus for Mersana Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277